Latest / Decera Clinical Education Oncology Podcast
PulseCast: Highlights in Multiple Myeloma From the 2025 ASH Annual Meeting
In this episode, Shaji K. Kumar, MD, reviews key highlights from ASH 2025 in multiple myeloma (MM), focusing on emerging data for bispecific antibodies and CAR T-cell therapies across earlier and later lines of treatment. The discussion covers the following:
MajesTEC-3: Results from the phase III study of teclistamab + daratumumab in R/R MM
RedirecTT-1: Updated efficacy and safety of talquetamab + teclistamab in R/R MM and extramedullary disease
CARTITUDE-4: Results following treatment with cilta-cel in patients with standard-risk cytogenetics
STEM: Preliminary safety and efficacy data from…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.